Silverfin false false 31/12/2023 31/12/2023 01/01/2023 no description of principal activity Mr Oliver John Hall 23/12/2022 Ms Yu Tung Law 23/12/2022 14555913 2023-12-31 14555913 bus:Director1 2023-12-31 14555913 bus:Director2 2023-12-31 14555913 core:CurrentFinancialInstruments 2023-12-31 14555913 2023-01-01 2023-12-31 14555913 bus:Micro-entities 2023-01-01 2023-12-31 14555913 bus:FullAccounts 2023-01-01 2023-12-31 14555913 bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 14555913 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 14555913 bus:Director1 2023-01-01 2023-12-31 14555913 bus:Director2 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Company No: 14555913 (England and Wales)

NEW WAVE BIOTECH LTD

Abridged Annual Report and Unaudited Financial Statements
For the financial year ended 31 December 2023

NEW WAVE BIOTECH LTD

ABRIDGED ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 December 2023

Contents

NEW WAVE BIOTECH LTD

COMPANY INFORMATION

For the financial year ended 31 December 2023
NEW WAVE BIOTECH LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2023
DIRECTORS Mr Oliver John Hall
Ms Yu Tung Law
REGISTERED OFFICE International House
61 Mosley Street
M2 3HZ
Manchester
United Kingdom
COMPANY NUMBER 14555913 (England and Wales)
ACCOUNTANT OnTheGo Accountants Limited
330 Holborn Gate
High Holborn
London
WC1V 7QH
NEW WAVE BIOTECH LTD

DIRECTORS' REPORT

For the financial year ended 31 December 2023
NEW WAVE BIOTECH LTD

DIRECTORS' REPORT

For the financial year ended 31 December 2023

DIRECTORS

The directors who served during the financial year and since the financial year end were as follows:

Mr Oliver John Hall
Ms Yu Tung Law

The Directors' Report has been prepared taking advantage of the small companies’ exemption of section 415A of the Companies Act 2006.



Approved by the Board of Directors and signed on its behalf by:

Ms Yu Tung Law
Director
International House
61 Mosley Street
M2 3HZ
Manchester
United Kingdom

13 February 2024

NEW WAVE BIOTECH LTD

PROFIT AND LOSS ACCOUNT

For the financial year ended 31 December 2023
NEW WAVE BIOTECH LTD

PROFIT AND LOSS ACCOUNT (continued)

For the financial year ended 31 December 2023
31.12.2023
£
Turnover 51,261
Other income 23
Staff Costs ( 124,405)
Depreciation and other amounts written off assets ( 558)
Other charges ( 34,518)
Loss before taxation ( 108,197)
Tax on loss 0
Loss for the financial year ( 108,197)
NEW WAVE BIOTECH LTD

BALANCE SHEET

As at 31 December 2023
NEW WAVE BIOTECH LTD

BALANCE SHEET (continued)

For the financial year ended 31 December 2023
31.12.2023
£
Fixed assets 2,185
Current assets 53,946
Prepayments and accrued income 395
Creditors: amounts falling due within one year 698
Net current assets 55,039
Total assets less current liabilities 57,224
Net assets 57,224
Capital and reserves 57,224

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of New Wave Biotech Ltd (registered number: 14555913) were approved and authorised for issue by the Board of Directors on 13 February 2024 and were signed on its behalf by:

Ms Yu Tung Law
Director
NEW WAVE BIOTECH LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
NEW WAVE BIOTECH LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 December 2023

1. Employees

31.12.2023
Number
Monthly average number of persons employed by the Company during the financial year, including directors 5